What are the diagnostic criteria and treatment for diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Diabetic Ketoacidosis (DKA)

DKA is diagnosed when blood glucose >250 mg/dL (or prior diabetes history), venous pH <7.3, serum bicarbonate <15 mEq/L, and elevated blood β-hydroxybutyrate are present simultaneously. 1

Core Diagnostic Triad

The diagnosis requires three components present at the same time: 2

  • Hyperglycemia: Blood glucose >250 mg/dL 1
  • Metabolic acidosis: Venous pH <7.3 AND serum bicarbonate <15 mEq/L 1
  • Ketosis: Elevated blood β-hydroxybutyrate (β-OHB) 2

Critical Exception: Euglycemic DKA

Approximately 10% of DKA cases present with glucose <200 mg/dL, termed euglycemic DKA. 3 This occurs with:

  • SGLT2 inhibitor use (most common cause) 3, 2
  • Pregnancy 3
  • Reduced food intake/starvation 3
  • Chronic alcohol use 3
  • Chronic liver disease 3

Never dismiss DKA because glucose is <250 mg/dL—euglycemic DKA is increasingly common, especially with SGLT2 inhibitors. 2

Severity Classification

DKA severity determines monitoring intensity and prognosis: 1

  • Mild: pH 7.25-7.30, bicarbonate 15-18 mEq/L, alert mental status 1
  • Moderate: pH 7.00-7.24, bicarbonate 10-15 mEq/L, drowsy/lethargic 1
  • Severe: pH <7.00, bicarbonate <10 mEq/L, stuporous/comatose—requires intensive monitoring including possible central venous and arterial pressure monitoring 1

Essential Laboratory Workup

Obtain immediately upon presentation: 1

  • Complete metabolic panel (electrolytes, BUN, creatinine) 1
  • Venous blood gas (pH, bicarbonate) 1
  • Blood β-hydroxybutyrate (β-OHB)—preferred ketone measurement 1, 2
  • Complete blood count 1
  • Urinalysis 1
  • Serum osmolality 2
  • Electrocardiogram 2
  • Calculate anion gap: [Na⁺] - ([Cl⁻] + [HCO₃⁻]), should be >10-12 mEq/L in DKA 1
  • Correct serum sodium for hyperglycemia: [measured Na] + [(glucose - 100)/100] × 1.6 1

Additional Tests When Indicated

  • Bacterial cultures (blood, urine, throat) if infection suspected 1
  • Amylase, lipase if abdominal pain present 4
  • Troponin, creatine kinase if cardiac symptoms 4
  • Chest radiography if respiratory symptoms 4
  • A1C level 4

Critical Ketone Measurement Pitfall

Never rely on urine ketones or nitroprusside-based tests for diagnosis or monitoring. 1, 2 These methods only measure acetoacetate and acetone, completely missing β-hydroxybutyrate—the predominant and strongest ketoacid in DKA. 1, 2 During treatment, β-OHB converts to acetoacetate, making nitroprusside tests paradoxically appear worse even as the patient improves. 1

Direct blood β-hydroxybutyrate measurement is the gold standard. 1, 3, 2


Treatment of Diabetic Ketoacidosis

Fluid Resuscitation

Begin aggressive fluid resuscitation with isotonic saline at 15-20 mL/kg/hour immediately to restore circulatory volume and tissue perfusion. 1

  • Subsequent fluid choice depends on hydration state, serum electrolytes, and urine output 1
  • Correct estimated fluid deficits within 24 hours 1
  • Monitor closely for fluid overload in patients with renal or cardiac compromise 1

Insulin Therapy

Start continuous IV regular insulin infusion at 0.1 units/kg/hour without an initial bolus. 1

  • If glucose does not fall by 50 mg/dL in the first hour, double the insulin infusion rate hourly until achieving a steady decline of 50-75 mg/dL per hour 1
  • When glucose reaches 200-250 mg/dL, add dextrose to IV fluids while continuing insulin infusion to clear ketones 1, 3
  • Continue insulin therapy until ketoacidosis resolves, regardless of glucose levels—premature termination before ketone clearance is a critical error 3

Transition to Subcutaneous Insulin

Administer basal subcutaneous insulin 2-4 hours before stopping IV insulin to prevent rebound hyperglycemia. 1

Potassium Replacement

If initial potassium <3.3 mEq/L, delay insulin therapy and aggressively replace potassium first to prevent fatal cardiac arrhythmias. 1

Once serum potassium <5.5 mEq/L and adequate urine output confirmed: 1

  • Add 20-30 mEq potassium per liter of IV fluid 1
  • Goal: maintain serum potassium 4-5 mEq/L 1
  • Continue until patient can tolerate oral supplementation 1

Bicarbonate Therapy

Do not administer bicarbonate except when pH <6.9. 1 If needed, add to IV fluids rather than giving as bolus. 5

Monitoring During Treatment

Draw blood every 2-4 hours to measure: 1, 2

  • Electrolytes 1
  • Glucose 1
  • Venous pH (arterial blood gases unnecessary after initial diagnosis) 1
  • β-hydroxybutyrate 1
  • Anion gap 1
  • BUN/creatinine 1
  • Serum osmolality 1

Venous pH adequately monitors acidosis resolution and is typically 0.03 units lower than arterial pH—avoid unnecessary arterial sticks. 1

Resolution Criteria

DKA is resolved when ALL of the following are met: 1, 2

  • Glucose <200 mg/dL 1
  • Venous pH >7.3 1
  • Serum bicarbonate ≥18 mEq/L 1
  • Anion gap ≤12 mEq/L 1

Ketonemia typically takes longer to clear than hyperglycemia—continue monitoring β-OHB until normalized. 1

Special Monitoring Consideration

Monitor closely for cerebral edema during treatment, especially with overly aggressive fluid resuscitation, particularly in children. 1

Identify and Treat Precipitating Causes

Failing to identify and treat the underlying precipitating cause leads to DKA recurrence. 1 Common precipitants include:

  • Infection 1
  • Missed insulin doses 3
  • New-onset diabetes 6
  • Myocardial infarction 4
  • Pancreatitis 4
  • Medications (SGLT2 inhibitors, corticosteroids) 3

Patient Education for Prevention

Provide education on: 1

  • Recognition of early DKA symptoms 1
  • Sick-day management rules 4
  • Never stopping basal insulin even when not eating 3
  • Checking blood ketones when glucose >200 mg/dL or during illness 3
  • Importance of medication compliance 6

References

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Diabetic Ketoacidosis (DKA) in Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Research

Diabetic ketoacidosis: evaluation and treatment.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.